Thrivent Financial for Lutherans Purchases 23,045 Shares of Silicon Laboratories Inc. (NASDAQ:SLAB)

Thrivent Financial for Lutherans raised its position in Silicon Laboratories Inc. (NASDAQ:SLAB) by 17.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 154,593 shares of the semiconductor company’s stock after purchasing an additional 23,045 shares during the quarter. Thrivent Financial for Lutherans owned 0.48% of Silicon Laboratories worth $19,204,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in SLAB. Natixis Advisors LLC boosted its position in Silicon Laboratories by 6.2% during the 3rd quarter. Natixis Advisors LLC now owns 12,050 shares of the semiconductor company’s stock worth $1,393,000 after buying an additional 708 shares during the period. Quest Partners LLC bought a new stake in shares of Silicon Laboratories in the third quarter worth $426,000. Advisors Asset Management Inc. increased its holdings in Silicon Laboratories by 159.4% in the third quarter. Advisors Asset Management Inc. now owns 275 shares of the semiconductor company’s stock valued at $32,000 after purchasing an additional 169 shares during the period. Intech Investment Management LLC raised its position in Silicon Laboratories by 82.9% during the 3rd quarter. Intech Investment Management LLC now owns 12,837 shares of the semiconductor company’s stock worth $1,484,000 after purchasing an additional 5,818 shares during the last quarter. Finally, Citigroup Inc. lifted its holdings in Silicon Laboratories by 37.6% during the 3rd quarter. Citigroup Inc. now owns 59,064 shares of the semiconductor company’s stock worth $6,826,000 after buying an additional 16,134 shares during the period.

Insider Buying and Selling

In other news, Director William G. Bock sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $149.43, for a total value of $149,430.00. Following the completion of the sale, the director now directly owns 31,115 shares of the company’s stock, valued at $4,649,514.45. This represents a 3.11 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Navdeep S. Sooch sold 2,360 shares of the company’s stock in a transaction on Wednesday, February 5th. The stock was sold at an average price of $149.00, for a total value of $351,640.00. Following the sale, the director now owns 400,567 shares of the company’s stock, valued at $59,684,483. This trade represents a 0.59 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 5,360 shares of company stock worth $782,610 in the last quarter. Insiders own 1.72% of the company’s stock.

Analyst Upgrades and Downgrades

SLAB has been the subject of a number of analyst reports. Stifel Nicolaus raised their price objective on Silicon Laboratories from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Monday, January 6th. Barclays boosted their price target on shares of Silicon Laboratories from $75.00 to $120.00 and gave the stock an “equal weight” rating in a research report on Friday, January 17th. KeyCorp increased their price objective on shares of Silicon Laboratories from $115.00 to $160.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 22nd. StockNews.com upgraded shares of Silicon Laboratories from a “sell” rating to a “hold” rating in a report on Tuesday. Finally, Susquehanna started coverage on Silicon Laboratories in a report on Tuesday, December 17th. They set a “neutral” rating and a $130.00 price target for the company. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $136.20.

Silicon Laboratories Stock Down 1.0 %

NASDAQ SLAB opened at $123.57 on Friday. Silicon Laboratories Inc. has a 52 week low of $94.00 and a 52 week high of $160.00. The business has a 50 day moving average price of $138.03 and a 200-day moving average price of $123.05. The company has a market cap of $4.01 billion, a price-to-earnings ratio of -20.80 and a beta of 1.15.

Silicon Laboratories (NASDAQ:SLAB) last announced its quarterly earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) EPS for the quarter, meeting analysts’ consensus estimates of ($0.11). Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The business had revenue of $166.25 million during the quarter, compared to analyst estimates of $166.09 million. During the same quarter in the previous year, the business posted ($1.19) EPS. Silicon Laboratories’s quarterly revenue was up 91.4% on a year-over-year basis. On average, equities research analysts anticipate that Silicon Laboratories Inc. will post -0.97 earnings per share for the current year.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.